Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

18F-Fluorodeoxyglucose-Positron Emission Tomography-Computed Tomography findings of Polymyalgia Rheumatica in Patients with Large Vessel vasculitis

Version 1 : Received: 9 October 2023 / Approved: 10 October 2023 / Online: 10 October 2023 (02:58:42 CEST)

A peer-reviewed article of this Preprint also exists.

Heras-Recuero, E.; Martínez de Bourio-Allona, M.; Landaeta-Kancev, L.C.; Blázquez-Sánchez, T.; Torres-Roselló, A.; Álvarez-Rubio, M.; Belhaj-Gandar, M.; Martínez-López, J.A.; Martínez-Dhier, L.; Llorca, J.; Largo, R.; González-Gay, M.Á. 18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography Findings of Polymyalgia Rheumatica in Patients with Giant Cell Arteritis. J. Clin. Med. 2023, 12, 6983. Heras-Recuero, E.; Martínez de Bourio-Allona, M.; Landaeta-Kancev, L.C.; Blázquez-Sánchez, T.; Torres-Roselló, A.; Álvarez-Rubio, M.; Belhaj-Gandar, M.; Martínez-López, J.A.; Martínez-Dhier, L.; Llorca, J.; Largo, R.; González-Gay, M.Á. 18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography Findings of Polymyalgia Rheumatica in Patients with Giant Cell Arteritis. J. Clin. Med. 2023, 12, 6983.

Abstract

Objective: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are often overlapping conditions. We aimed to determine whether 18F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) is useful in identifying PMR in the setting of large vessel vasculitis (LVV)-GCA. Methods: Patients diagnosed with LVV-GCA by PET-CT at a tertiary referral hospital for a population of 450,000 people over a two-year period were reviewed. Scoring was performed based on potential significant FDG uptake at up to 16 sites in nine different extravascular areas (SCORE 16). Differences in extravascular sites of significant FDG uptake were evaluated between LVV-GCA with a clinical diagnosis of PMR or not. Results: Fifty-four patients were diagnosed with LVV-GCA by 18F-FDG-PET-CT. Of them, 21 (38.8%) were clinically diagnosed with PMR. Significant extravascular FDG uptake was more frequently observed in those with a clinical diagnosis of PMR. In this sense, the SCORE 16 was higher in those with clinical PMR (5.10 ± 4.05 versus 1.73 ± 2.31 in those without a clinical diagnosis of PMR; p< 0.001). A SCORE 16 involving more than 4 sites of significant FDG uptake yielded a sensitivity of 52% and a specificity of 91% for establishing a clinical diagnosis of PMR associated with LVV-GCA. The best areas of significant FDG uptake to clinically identify PMR in patients with LVV were the shoulder, the greater trochanter and the lumbar interspinous regions with an area under the ROC curve of 0.810 (0.691-0.930). Conclusion: Significant extravascular 18F-FDG-PET-CT uptake may help establish a clinical diagnosis of PMR in patients with LVV-GCA. These patients are more commonly diagnosed with PMR if they have significant FDG uptake in the shoulder, greater trochanter, and lumbar interspinous areas.

Keywords

Positron emission computed tomography (PET-CT) with 18F-fluorodeoxyglucose (FDG), FDG uptake, large vessel vasculitis, giant cell arteritis, polymyalgia rheumatica.

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.